<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Reports of Biochemistry and Molecular Biology</title>
<title_fa></title_fa>
<short_title>rbmb.net</short_title>
<subject>Basic Sciences</subject>
<web_url>http://rbmb.net</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2322-3480</journal_id_issn>
<journal_id_issn_online>2322-3480</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/rbmb</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1401</year>
	<month>5</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2022</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<volume>11</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Association of Tumor Necrosis Factor-α and Myeloperoxidase enzyme with Severe Asthma: A comparative study</title>
	<subject_fa>بیوشیمی</subject_fa>
	<subject>Biochemistry</subject>
	<content_type_fa>مقالات اصلی</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;&lt;em&gt;Background: &lt;/em&gt;&lt;/strong&gt;Tumor necrosis factor-alpha (TNF-&amp;alpha;) may stimulate airway hyperresponsiveness in asthma,&amp;nbsp;which is also affected by neutrophils activity. The latter can be determined indirectly by evaluating&amp;nbsp;myeloperoxidase (MPO) activity. The insufficient studies that investigated the combined association of&lt;br&gt;
serum TNF-&amp;alpha; and MPO with asthma was objective of this study.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Methods:&lt;/em&gt;&lt;/strong&gt; A case-control study included 110-asthmatics besides 92-controls. All participants underwent&amp;nbsp;venous sampling for TNF-&amp;alpha; and MPO&amp;nbsp; immunoassays. A percentage of predicted &amp;#39;&amp;#39;forced expiratory volume&amp;nbsp;in one second (FEV1%)&amp;#39;&amp;#39;, and the &amp;#39;&amp;#39;peak expiratory flow rate (PEF/L)&amp;#39;&amp;#39; of all participants were verified. The&amp;nbsp;statistical analyses had done using SPSS V-25. The accuracy, specificity, sensitivity, and significance of&amp;nbsp;both biomarkers to distinguish asthma examined &amp;#39;&amp;#39;under the ROC-curves&amp;#39;&amp;#39;.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Results:&lt;/em&gt;&lt;/strong&gt; High TNF-&amp;alpha; levels observed among the controls(p-0.006), opposing the higher MPO levels among&amp;nbsp;the patients(p-0.00). There were nonsignificant variations of two biomarkers between the treatment groups&amp;nbsp;and nonsignificant correlations of MPO with FEV1 and PEF. There was a significant correlation of MPO&amp;nbsp;with the TNF-&amp;alpha; levels of all participants. The TNF-&amp;alpha; showed lower sensitivity, specificity, and accuracy to&amp;nbsp;diagnose asthma. There were no MPO differences according to asthma levels. The TNF-&amp;alpha; was higher&amp;nbsp;among the severe asthmatics significantly.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Conclusions:&lt;/em&gt;&lt;/strong&gt; TNF-&amp;alpha; may be a contributory particle for neutrophilic inflammation of severe asthma. MPO&amp;nbsp;levels were significantly higher among asthmatics, whereas TNF-&amp;alpha; levels were lower. TNF-&amp;alpha; levels were&amp;nbsp;higher among those with severe compared to mild/moderate asthma. The MPO level has a significant&lt;br&gt;
predictive capacity compared to TNF-&amp;alpha; for distinguishing asthma from healthy subjects.&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Asthma, Inflammation, MPO, Neutrophils, TNF-α.</keyword>
	<start_page>238</start_page>
	<end_page>245</end_page>
	<web_url>http://rbmb.net/browse.php?a_code=A-10-872-4&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Ahmed Khalid </first_name>
	<middle_name></middle_name>
	<last_name>Aldhalmi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012194</code>
	<orcid>100319475328460012194</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>The University of Mashreq, College of Pharmacy, Baghdad, Iraq.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ali Jihad Hemid </first_name>
	<middle_name></middle_name>
	<last_name>Al-Athari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012195</code>
	<orcid>100319475328460012195</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Al-Mustaqbal University College, Department of Pharmacy, Iraq.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hayder Abdul-Amir </first_name>
	<middle_name></middle_name>
	<last_name>Makki Al-Hindy</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>phar.hayder.abdul@uobabylon.edu.iq</email>
	<code>100319475328460012196</code>
	<orcid>100319475328460012196</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>College of Pharmacy, University of Babylon, Babylon, Iraq.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
